Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(16)
Published: April 2, 2024
Atherosclerotic
plaque
formation
is
considered
the
primary
pathological
mechanism
underlying
atherosclerotic
cardiovascular
diseases,
leading
to
severe
events
such
as
stroke,
acute
coronary
syndromes,
and
even
sudden
cardiac
death.
Early
detection
timely
intervention
of
plaques
are
challenging
due
lack
typical
symptoms
in
initial
stages.
Therefore,
precise
early
play
a
crucial
role
risk
stratification
achieving
favorable
post-interventional
outcomes.
The
continuously
advancing
nanoplatforms
have
demonstrated
numerous
advantages
including
high
signal-to-noise
ratio,
enhanced
bioavailability,
specific
targeting
capabilities
for
imaging
agents
therapeutic
drugs,
enabling
effective
visualization
management
plaques.
Motivated
by
these
superior
properties,
various
noninvasive
modalities
recognition
preliminary
stage
atherosclerosis
comprehensively
summarized.
Additionally,
several
strategies
proposed
enhance
efficacy
treating
Finally,
existing
challenges
promising
prospects
accelerating
clinical
translation
nanoplatform-based
molecular
therapy
discussed.
In
conclusion,
this
review
provides
an
insightful
perspective
on
diagnosis
Advanced Healthcare Materials,
Journal Year:
2022,
Volume and Issue:
12(7)
Published: Nov. 26, 2022
Nanocatalysts,
a
class
of
nanomaterials
with
intrinsic
enzyme-like
activities,
have
been
widely
investigated
for
cancer
catalytic
therapy
in
recent
years.
However,
precise
construction
nanocatalysts
excellent
enzyme
activity
and
biosafety
tumor
still
remains
challenging.
Here,
biodegradable
nanocatalyst,
PEGylated
Cux
Mny
Sz
(PCMS),
is
reported
that
can
promote
cascade
reactions
microenvironment
(TME)
while
confining
off-target
side
effects
on
normal
tissues.
PCMS
not
only
catalyzes
the
conversion
endogenous
hydrogen
peroxide
(H2
O2
)
to
oxygen
(O2
via
catalase-like
then
superoxide
radical
(·O2-
oxidase-like
TME,
but
also
effectively
depletes
intracellular
glutathione
activity.
The
reactions,
by
taking
advantage
high
H2
level
cells,
result
an
enhanced
effect
generation
·O2-
.
More
importantly,
exhibits
prominent
photothermal
under
NIR-II
1064
nm
laser
irradiation
further
enhance
chemodynamic
(CDT)
efficacy
tumors.
In
addition,
biodegradation
TME
are
beneficial
magnetic
resonance
imaging,
photoacoustic
imaging
infrared
thermal
resulting
tracing
fate
vivo.
This
study
provides
new
tool
rational
design
TME-responsive
biocompatibility
therapy.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
17(2), P. 1174 - 1186
Published: Dec. 30, 2022
Metal–organic
frameworks
(MOF)
have
attracted
great
potential
in
sonodynamic
therapy
(SDT)
owing
to
large
sonosensitizers'
loading
and
fast
reactive
oxygen
species'
(ROS)
diffusion;
however,
the
low
ligand-to-metal
charge
transfer
efficiency
sharply
impairs
SDT
effect.
Herein,
we
report
design
of
MIL@Ag
heterostructures
with
high
electron–hole
pairs
separation
enhanced
diverse
ROS
generation
ability
for
deep-seated
cancer
treatment
bacterial
infection.
The
heterostructure
is
composed
Ti-based
MOFs
(named
MIL),
on
which
are
situ
assembled
silver
nanoparticles
(Ag
NPs).
electrochemical
experiments
density
functional
theory
calculations
verify
that
introduction
Ag
NPs
can
significantly
improve
electron
O2
adsorption
capacity
MIL.
Under
ultrasound
irradiation,
doped
trap
activated
electrons
from
MIL
reduce
surrounding
produce
superoxide
radicals
(•O2–),
while
holes
enable
oxidizing
H2O
hydroxyl
(•OH).
Thus,
they
efficiently
therapeutic
SDT.
MIL@Ag-PEG-mediated
implements
A549
cells'
killing
under
a
tissue
barrier
2
cm
eradicates
infection
Staphylococcus
aureus,
thus
promoting
wound
healing.
Therefore,
MIL@Ag-PEG
provides
promising
strategy
augmenting
performance
by
rational
sonosensitizers.
Advanced Drug Delivery Reviews,
Journal Year:
2023,
Volume and Issue:
194, P. 114709 - 114709
Published: Jan. 20, 2023
Atherosclerosis,
a
chronic
cardiovascular
disease
caused
by
plaque
development
in
arteries,
remains
leading
cause
of
morbidity
and
mortality.
Atherosclerotic
plaques
are
characterized
the
expression
regulation
key
molecules
such
as
cell
surface
receptors,
cytokines,
signaling
pathway
proteins,
potentially
facilitating
precise
diagnosis
treatment
on
molecular
level
specifically
targeting
characteristic
molecules.
In
this
review,
we
highlight
recent
progress
past
five
years
developing
molecularly
targeted
nanomedicine
for
imaging
detection
atherosclerosis
with
use
inorganic
nanoparticles.
Through
delivery
contrast
nanoparticles
to
specific
atherogenesis,
atherosclerotic
at
different
stages
could
be
identified
monitored
via
various
modalities.
We
also
review
therapeutic
approaches
that
target
regulate
associated
lipid
regulation,
inflammation,
apoptosis.
The
is
concluded
discussion
current
challenges
future
treatment.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(36)
Published: Oct. 28, 2023
Abstract
With
the
changing
disease
spectrum,
atherosclerosis
has
become
increasingly
prevalent
worldwide
and
associated
diseases
have
emerged
as
leading
cause
of
death.
Due
to
their
fascinating
physical,
chemical,
biological
characteristics,
nanomaterials
are
regarded
a
promising
tool
tackle
enormous
challenges
in
medicine.
The
emerging
discipline
nanomedicine
filled
huge
application
gap
atherosclerotic
field,
ushering
new
generation
diagnosis
treatment
strategies.
Herein,
based
on
essential
pathogenic
contributors
atherogenesis,
well
distinct
composition/structural
synthesis
strategies,
surface
design
nanoplatforms,
three
major
branches
(nanodiagnosis,
nanotherapy,
nanotheranostic)
elaborated.
Then,
state‐of‐art
studies
containing
sequence
representative
significant
achievements
summarized
detail
with
an
emphasis
intrinsic
interaction/relationship
between
nanomedicines
atherosclerosis.
Particularly,
attention
is
paid
biosafety
nanomedicines,
which
aims
pave
way
for
future
clinical
translation
this
burgeoning
field.
Finally,
comprehensive
review
concluded
by
proposing
unresolved
key
scientific
issues
sharing
vision
expectation
future,
fully
elucidating
closed
loop
from
atherogenesis
paradigm
advancing
early
achievement
applications.
Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
33(27)
Published: April 19, 2023
Abstract
Nucleotide‐binding
domain
and
leucine
rich
repeat
family
pyrin
containing
3
(NLRP3)
inflammasomes
are
implicated
in
diverse
inflammatory
diseases,
so
their
activation
needs
to
be
tightly
controlled.
Over
generation
of
reactive
oxygen
species
(ROS)
is
a
key
factor
NLRP3
inflammasome
activation.
Consequently,
nanozymes
with
ROS
scavenging
ability
potential
inhibitors
promising
therapeutic
agents
for
related
diseases.
Herein,
type
2D
cobalt
hydroxide
oxide
nanosheets
(Co
NSs),
nanozyme
excellent
multienzyme‐like
activity,
possessing
peroxidase
(POD),
catalase
(CAT),
superoxide
dismutase
(SOD)
activities,
exhibits
superior
properties
protects
cells
from
oxidative
damage.
Density
functional
theory
(DFT)
calculations
further
reveal
these
enzyme‐like
catalytic
reactions
eliminating
spontaneous
CAT
dominant
under
physiological
conditions.
Performing
multienzyme
properties,
Co
NSs
present
anti‐inflammation
activity
by
blocking
oligomerization
ASC
speck
formation,
thereby
inhibiting
assembly
Importantly,
treatment
attenuates
the
severity
LPS‐induced
systemic
inflammation
DSS‐induced
colitis.
This
study
highlights
successful
strategy
utilizing
cobalt‐based
scavenge
provides
valuable
insights
into
underlying
mechanism,
demonstrating
effects
prevention
NLRP3‐associatied
Exploration,
Journal Year:
2023,
Volume and Issue:
4(3)
Published: Dec. 7, 2023
Abstract
Atherosclerosis,
a
chronic
disease
associated
with
metabolism,
poses
significant
risk
to
human
well‐being.
Currently,
existing
treatments
for
atherosclerosis
lack
sufficient
efficiency,
while
the
utilization
of
surface‐modified
nanoparticles
holds
potential
deliver
highly
effective
therapeutic
outcomes.
These
can
target
and
bind
specific
receptors
that
are
abnormally
over‐expressed
in
atherosclerotic
conditions.
This
paper
reviews
recent
research
(2018–present)
advances
various
ligand‐modified
nanoparticle
systems
targeting
by
specifically
signature
molecules
hope
precise
treatment
at
molecular
level
concludes
discussion
challenges
prospects
this
field.
The
intention
review
is
inspire
novel
concepts
design
advancement
targeted
nanomedicines
tailored
atherosclerosis.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(12), P. 11749 - 11763
Published: June 15, 2023
Chimeric
antigen
receptor
(CAR)
T
cell
therapy
holds
great
promise
in
the
treatment
of
hematological
malignancies
but
performs
poorly
solid
tumors
due
to
tumor
immunosuppressive
microenvironment.
Herein,
a
multifunctional
nanocatalyst
(APHA@CM)
was
prepared
by
encapsulating
horseradish
peroxidase
(HRP)-loaded
Au/polydopamine
nanoparticles
(Au/PDA
NPs)
and
Ag2S
quantum
dots
with
CAR
membranes
improve
tumors.
The
APHA@CM
has
excellent
multimodal
imaging
capability
precisely
guide
scope
time
window
for
nanocatalyst-induced
microenvironment
regulation
therapy.
oxidase-like
activity
Au
NPs
inhibited
glycolytic
metabolism
cells,
reducing
lactate
efflux,
reprogramming
immunosuppression,
ultimately
increasing
activation
within
Additionally,
hypoxia
environment
could
be
relieved
HRP
enhance
Au/PDA
NPs-induced
synergistic
sonodynamic/photothermal
(SDT/PTT),
thereby
promoting
immunogenic
death
NALM
6
cells
enhancing
cell-mediated
immune
reprogramming.
When
this
strategy
utilized
treat
tumors,
it
not
only
completely
eliminated
also
formed
long-term
memory
effect
inhibit
metastasis
recurrence.
This
work
offers
tumor.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(9)
Published: Nov. 7, 2023
Sono-photodynamic
therapy
is
hindered
by
the
limited
tissue
penetration
depth
of
external
light
source
and
quick
recombination
electron-hole
owing
to
random
movement
charge
carriers.
In
this
study,
orthorhombic
ZnSnO